메뉴 건너뛰기




Volumn 5, Issue 4, 2012, Pages 187-198

Relationship between 25-OH-D serum level and relapse rate in multiple sclerosis patients before and after vitamin D supplementation

Author keywords

multiple sclerosis; relapse rate; vitamin D; vitamin D supplementation

Indexed keywords

25 HYDROXYVITAMIN D; COLECALCIFEROL;

EID: 84863587083     PISSN: 17562856     EISSN: 17562864     Source Type: Journal    
DOI: 10.1177/1756285612447090     Document Type: Article
Times cited : (60)

References (63)
  • 1
    • 34447508481 scopus 로고    scopus 로고
    • Environmental risk factors for multiple sclerosis. Part II: non-infectious factors
    • Ascherio A. Munger K.L. (2007) Environmental risk factors for multiple sclerosis. Part II: non-infectious factors. Ann Neurol 61: 504–513.
    • (2007) Ann Neurol , vol.61 , pp. 504-513
    • Ascherio, A.1    Munger, K.L.2
  • 3
    • 78650082615 scopus 로고    scopus 로고
    • Immunomodulatory effects of vitamin D on monocyte-derived dendritic cells in multiple sclerosis
    • Bartosik-Psujek H. Tabarkiewicz J. Pocisnska K. Stelmasiak Z. Rolinski J. (2010) Immunomodulatory effects of vitamin D on monocyte-derived dendritic cells in multiple sclerosis. Mult Scler 16: 1513–1516.
    • (2010) Mult Scler , vol.16 , pp. 1513-1516
    • Bartosik-Psujek, H.1    Tabarkiewicz, J.2    Pocisnska, K.3    Stelmasiak, Z.4    Rolinski, J.5
  • 4
    • 55249098110 scopus 로고    scopus 로고
    • Evaluation and correction of low vitamin D status
    • Binkley N. Krueger D. (2008) Evaluation and correction of low vitamin D status. Curr Osteoporos Rep 6: 95-99.
    • (2008) Curr Osteoporos Rep , vol.6 , pp. 95-99
    • Binkley, N.1    Krueger, D.2
  • 6
    • 63849282684 scopus 로고    scopus 로고
    • Prevention of non-vertebral fractures with oral vitamin D and dose dependency: a meta-analysis of randomized controlled trials
    • Bischoff-Ferrari H.A. Willett W.C. Wong J.B. Stuck A.E. Staehelin B. Orav E.J. et al. (2009) Prevention of non-vertebral fractures with oral vitamin D and dose dependency: a meta-analysis of randomized controlled trials. Arch Intern Med 169: 551–561.
    • (2009) Arch Intern Med , vol.169 , pp. 551-561
    • Bischoff-Ferrari, H.A.1    Willett, W.C.2    Wong, J.B.3    Stuck, A.E.4    Staehelin, B.5    Orav, E.J.6
  • 7
    • 77953328331 scopus 로고    scopus 로고
    • A phase I / II dose escalation trial of vitamin D 3 and calcium in multiple sclerosis
    • Burton J.M. Kimball S. Vieth R. Bar-Or A. Dosch H.M. Cheug R. et al. (2010) A phase I / II dose escalation trial of vitamin D 3 and calcium in multiple sclerosis. Neurology 74: 1852–1859.
    • (2010) Neurology , vol.74 , pp. 1852-1859
    • Burton, J.M.1    Kimball, S.2    Vieth, R.3    Bar-Or, A.4    Dosch, H.M.5    Cheug, R.6
  • 9
    • 77954546834 scopus 로고    scopus 로고
    • Measurement uncertainty of 25-OH vitamin D determination with different commercially available kits: impact on the clinical cut offs
    • Cavalier E. Rozet E. Gadisseur R. Carlisi A. Monge M. Chapelle J.P. et al. (2010) Measurement uncertainty of 25-OH vitamin D determination with different commercially available kits: impact on the clinical cut offs. Osteoporos Int 21: 1047–1051.
    • (2010) Osteoporos Int , vol.21 , pp. 1047-1051
    • Cavalier, E.1    Rozet, E.2    Gadisseur, R.3    Carlisi, A.4    Monge, M.5    Chapelle, J.P.6
  • 10
    • 66549129834 scopus 로고    scopus 로고
    • Immunomodulatory aspects of vitamin D in multiple sclerosis
    • Correale J. Ysrraelit M.C. Gaitan M.I. (2009) Immunomodulatory aspects of vitamin D in multiple sclerosis. Brain 132: 1146–1160.
    • (2009) Brain , vol.132 , pp. 1146-1160
    • Correale, J.1    Ysrraelit, M.C.2    Gaitan, M.I.3
  • 11
    • 78049509828 scopus 로고    scopus 로고
    • Gender differences in 1,25 dihydroxyvitamin D 3 immunomodulatory effects in multiple sclerosis patients and healthy subjects
    • Correale J. Ysrraelit M.C. Gaitan M.I. (2010) Gender differences in 1,25 dihydroxyvitamin D 3 immunomodulatory effects in multiple sclerosis patients and healthy subjects. J Immunol 185: 4948-4958.
    • (2010) J Immunol , vol.185 , pp. 4948-4958
    • Correale, J.1    Ysrraelit, M.C.2    Gaitan, M.I.3
  • 12
    • 84887844827 scopus 로고    scopus 로고
    • Efficacy of vitamin D supplementation in multiple sclerosis (EVIDIMS Trial): study protocol for a randomized trial
    • Dorr J. Ohlraun S. Skarabis H. Paul F. (2012) Efficacy of vitamin D supplementation in multiple sclerosis (EVIDIMS Trial): study protocol for a randomized trial. Trials 13: 15.
    • (2012) Trials , vol.13 , pp. 15
    • Dorr, J.1    Ohlraun, S.2    Skarabis, H.3    Paul, F.4
  • 13
    • 38949107656 scopus 로고    scopus 로고
    • Environmental factors and multiple sclerosis
    • Ebers G.C. (2008) Environmental factors and multiple sclerosis. Lancet Neurol 7: 268–277.
    • (2008) Lancet Neurol , vol.7 , pp. 268-277
    • Ebers, G.C.1
  • 14
    • 58149085571 scopus 로고    scopus 로고
    • Switching first-line disease-modifying therapy after failure: impact on the course of relapsing-remitting multiple sclerosis
    • Gajofatto A. Baccheti P. Grimes B. High A. Waubant E. (2009) Switching first-line disease-modifying therapy after failure: impact on the course of relapsing-remitting multiple sclerosis. Mult Scler 15: 50–58.
    • (2009) Mult Scler , vol.15 , pp. 50-58
    • Gajofatto, A.1    Baccheti, P.2    Grimes, B.3    High, A.4    Waubant, E.5
  • 15
    • 0022969013 scopus 로고
    • Multiple sclerosis: decreased relapse rate through dietary supplementation with calcium, magnesium and vitamin D
    • Goldberg P. Fleming M.C. Picard E.H. (1986) Multiple sclerosis: decreased relapse rate through dietary supplementation with calcium, magnesium and vitamin D. Med Hypotheses 21: 193–200.
    • (1986) Med Hypotheses , vol.21 , pp. 193-200
    • Goldberg, P.1    Fleming, M.C.2    Picard, E.H.3
  • 16
    • 21344463548 scopus 로고    scopus 로고
    • Benefits and requirements of vitamin D for optimal health: a review
    • Grant W.B. Holick M.F. (2005) Benefits and requirements of vitamin D for optimal health: a review. Altern Med Rev 10: 94–111.
    • (2005) Altern Med Rev , vol.10 , pp. 94-111
    • Grant, W.B.1    Holick, M.F.2
  • 17
    • 20044388168 scopus 로고    scopus 로고
    • Twenty-four-month comparison of immunomodulatory treatments – a retrospective open label study in 308 RRMS patients treated with beta interferons or glatiramer acetate (Copaxone®)
    • Haas J. Firzlaff M. (2005) Twenty-four-month comparison of immunomodulatory treatments – a retrospective open label study in 308 RRMS patients treated with beta interferons or glatiramer acetate (Copaxone®). Eur J Neurol 12: 425–431.
    • (2005) Eur J Neurol , vol.12 , pp. 425-431
    • Haas, J.1    Firzlaff, M.2
  • 18
    • 57049086978 scopus 로고    scopus 로고
    • Global vitamin D levels in relation to age, gender, skin pigmentation and latitude: an ecologic meta-regression analysis
    • Hagenau T. Vest R. Gissel T.N. Poulsen C.S. Erlandsem M. Mosekilde L. et al. (2009) Global vitamin D levels in relation to age, gender, skin pigmentation and latitude: an ecologic meta-regression analysis. Osteoporos Int 20: 133–140.
    • (2009) Osteoporos Int , vol.20 , pp. 133-140
    • Hagenau, T.1    Vest, R.2    Gissel, T.N.3    Poulsen, C.S.4    Erlandsem, M.5    Mosekilde, L.6
  • 19
    • 77249132585 scopus 로고    scopus 로고
    • Vitamin D intake needed to maintain target serum 25-hydroxyvitamin D concentrations in participants with low sun exposure and dark skin pigmentation is substantially higher than current recommendations
    • Hall L.M. Kimlin M.G. Aronov P.A. Hammock B.D. Slusser J.R. Woodhouse L.R. (2010) Vitamin D intake needed to maintain target serum 25-hydroxyvitamin D concentrations in participants with low sun exposure and dark skin pigmentation is substantially higher than current recommendations. J Nutr 140: 542–550.
    • (2010) J Nutr , vol.140 , pp. 542-550
    • Hall, L.M.1    Kimlin, M.G.2    Aronov, P.A.3    Hammock, B.D.4    Slusser, J.R.5    Woodhouse, L.R.6
  • 20
    • 78650174045 scopus 로고    scopus 로고
    • Assessment of evidence for a protective role of vitamin D in multiple sclerosis
    • Hanwell H.E.C. Banwell B. (2011) Assessment of evidence for a protective role of vitamin D in multiple sclerosis. Biochim Biophys Acta 1812: 202–212.
    • (2011) Biochim Biophys Acta , vol.1812 , pp. 202-212
    • Hanwell, H.E.C.1    Banwell, B.2
  • 21
    • 0033807020 scopus 로고    scopus 로고
    • Vitamin D: how much do we need and how much is too much?
    • Heaney R. (2000) Vitamin D: how much do we need and how much is too much? Osteoporos Int 11: 553–555.
    • (2000) Osteoporos Int , vol.11 , pp. 553-555
    • Heaney, R.1
  • 22
    • 0037215304 scopus 로고    scopus 로고
    • Human serum 25-hydroxycholecalciferol response to extended oral dosing with cholecalciferol
    • Heaney R.P. Davies K.M. Chen T.C. Holick M.F. Bager-Lux J. (2003) Human serum 25-hydroxycholecalciferol response to extended oral dosing with cholecalciferol. Am J Clin Nutr 77: 204–210.
    • (2003) Am J Clin Nutr , vol.77 , pp. 204-210
    • Heaney, R.P.1    Davies, K.M.2    Chen, T.C.3    Holick, M.F.4    Bager-Lux, J.5
  • 23
    • 79951832240 scopus 로고    scopus 로고
    • Why the IOM recommendations for vitamin D are deficient
    • Heaney R.P. Holick M.F. (2011) Why the IOM recommendations for vitamin D are deficient. J Bone Min Res 26: 455–457.
    • (2011) J Bone Min Res , vol.26 , pp. 455-457
    • Heaney, R.P.1    Holick, M.F.2
  • 25
    • 16544381338 scopus 로고    scopus 로고
    • Sunlight and vitamin D for bone health and prevention of autoimmune diseases, cancers, and cardiovascular disease
    • Holick M.F. (2004) Sunlight and vitamin D for bone health and prevention of autoimmune diseases, cancers, and cardiovascular disease. Am J Clin Nutr 80(Suppl.): 1678S–1688S.
    • (2004) Am J Clin Nutr , vol.80 , pp. 1678S-1688S
    • Holick, M.F.1
  • 26
    • 34447514029 scopus 로고    scopus 로고
    • Vitamin D deficiency
    • Holick M.F. (2007) Vitamin D deficiency. N Engl J Med 357: 266–281.
    • (2007) N Engl J Med , vol.357 , pp. 266-281
    • Holick, M.F.1
  • 27
    • 78650876692 scopus 로고    scopus 로고
    • Evolutionary, physiological and health perspectives
    • Holick M.F. (2011) Evolutionary, physiological and health perspectives. Curr Drug Targets 12: 4-18.
    • (2011) Curr Drug Targets , vol.12 , pp. 4-18
    • Holick, M.F.1
  • 28
    • 13244264697 scopus 로고    scopus 로고
    • Circulating 25-hydroxyvitamin D levels indicative of vitamin D sufficiency: implications for establishing a new effective dietary intake recommendation for vitamin D
    • Hollis B.W. (2005) Circulating 25-hydroxyvitamin D levels indicative of vitamin D sufficiency: implications for establishing a new effective dietary intake recommendation for vitamin D. J Nutr 135: 317–322.
    • (2005) J Nutr , vol.135 , pp. 317-322
    • Hollis, B.W.1
  • 29
    • 40549104752 scopus 로고    scopus 로고
    • Pharmacokinetics of a single, large dose of cholecalciferol
    • Ilahi M. Armas L.A.G. Heaney R.P. (2008) Pharmacokinetics of a single, large dose of cholecalciferol. Am J Clin Nutr 87: 688–691.
    • (2008) Am J Clin Nutr , vol.87 , pp. 688-691
    • Ilahi, M.1    Armas, L.A.G.2    Heaney, R.P.3
  • 30
    • 51649125765 scopus 로고    scopus 로고
    • Comparison of daily, weekly, and monthly vitamin D 3 in ethanol dosing protocols for two months in elderly hip fracture patients
    • Ish-Shalom S. Segal E. Salganik T. Raz B. Bromberg I.L. Vieth R. (2009) Comparison of daily, weekly, and monthly vitamin D 3 in ethanol dosing protocols for two months in elderly hip fracture patients. J Clin Endocrinol Metab 93: 3430–3435.
    • (2009) J Clin Endocrinol Metab , vol.93 , pp. 3430-3435
    • Ish-Shalom, S.1    Segal, E.2    Salganik, T.3    Raz, B.4    Bromberg, I.L.5    Vieth, R.6
  • 31
    • 84863600623 scopus 로고    scopus 로고
    • Effect of vitamin D 3 supplementation on relapses, disease progression and measures of function in persons with multiple sclerosis: exploratory outcomes from a double-blind randomised controlled trial
    • Epub ahead of print
    • Kampman M.T. Steffensen L.H. Mellgren S.I. Jørgensen L. (2012) Effect of vitamin D 3 supplementation on relapses, disease progression and measures of function in persons with multiple sclerosis: exploratory outcomes from a double-blind randomised controlled trial. Mult Scler [Epub ahead of print].
    • (2012) Mult Scler
    • Kampman, M.T.1    Steffensen, L.H.2    Mellgren, S.I.3    Jørgensen, L.4
  • 32
    • 84863586189 scopus 로고    scopus 로고
    • Course of relapsing-remitting multiple sclerosis before, during and after natalizumab
    • Kaufman M.D. Lee R. Norton H. (2011) Course of relapsing-remitting multiple sclerosis before, during and after natalizumab. Mult Scler 7: 90–94.
    • (2011) Mult Scler , vol.7 , pp. 90-94
    • Kaufman, M.D.1    Lee, R.2    Norton, H.3
  • 33
    • 79953324326 scopus 로고    scopus 로고
    • Vitamin D has a direct immunomodulatory effect on CD8+ T cells of patients with early multiple sclerosis and in healthy controls
    • Lysandropoulos A.P. Jaquiéry E. Jilek S. Pantealo G. Schluep M. Du Pasquier R.A. (2011) Vitamin D has a direct immunomodulatory effect on CD8+ T cells of patients with early multiple sclerosis and in healthy controls. J Neuroimmunol 233: 240–244.
    • (2011) J Neuroimmunol , vol.233 , pp. 240-244
    • Lysandropoulos, A.P.1    Jaquiéry, E.2    Jilek, S.3    Pantealo, G.4    Schluep, M.5    Du Pasquier, R.A.6
  • 34
    • 0037223587 scopus 로고    scopus 로고
    • Cytokine profile in patients with multiple sclerosis following vitamin D supplementation
    • Mahon B.D. Gordon S.A. Cruz J. Cosman F. Cantorna M.T. (2003) Cytokine profile in patients with multiple sclerosis following vitamin D supplementation. J Neuroimmunol 134: 128–132.
    • (2003) J Neuroimmunol , vol.134 , pp. 128-132
    • Mahon, B.D.1    Gordon, S.A.2    Cruz, J.3    Cosman, F.4    Cantorna, M.T.5
  • 35
    • 0034955141 scopus 로고    scopus 로고
    • Recommended diagnostic criteria for multiple sclerosis: guidelines from the International Panel on the diagnosis of multiple sclerosis
    • McDonald W.I. Compston A. Edan G. Goodkin D. Hartung H.P. Lublin F.D. et al. (2001) Recommended diagnostic criteria for multiple sclerosis: guidelines from the International Panel on the diagnosis of multiple sclerosis. Ann Neurol 50: 121–7.
    • (2001) Ann Neurol , vol.50 , pp. 121-127
    • McDonald, W.I.1    Compston, A.2    Edan, G.3    Goodkin, D.4    Hartung, H.P.5    Lublin, F.D.6
  • 37
    • 82555176755 scopus 로고    scopus 로고
    • Prevention and treatment of MS: studying the effects of vitamin D
    • Munger K.L. Ascherio A. (2011) Prevention and treatment of MS: studying the effects of vitamin D. Mult Scler 17: 1405–1411.
    • (2011) Mult Scler , vol.17 , pp. 1405-1411
    • Munger, K.L.1    Ascherio, A.2
  • 38
    • 33845720114 scopus 로고    scopus 로고
    • Serum 25-hydroxyvitamin D levels and risk of multiple sclerosis
    • Munger K.L. Levin L.I. Hollis B.W. Howard N.S. Ascherio A. (2006) Serum 25-hydroxyvitamin D levels and risk of multiple sclerosis. JAMA 296: 2832–2838.
    • (2006) JAMA , vol.296 , pp. 2832-2838
    • Munger, K.L.1    Levin, L.I.2    Hollis, B.W.3    Howard, N.S.4    Ascherio, A.5
  • 39
    • 69549114460 scopus 로고    scopus 로고
    • Clinical implications of a possible role of vitamin D in multiple sclerosis
    • Pierrot-Deseilligny C. (2009) Clinical implications of a possible role of vitamin D in multiple sclerosis. J Neurol 256: 1468–1479.
    • (2009) J Neurol , vol.256 , pp. 1468-1479
    • Pierrot-Deseilligny, C.1
  • 40
    • 77954353114 scopus 로고    scopus 로고
    • Is hypovitaminosis D one of the environmental risk factors for multiple sclerosis?
    • Pierrot-Deseilligny C. Souberbielle J.C. (2010) Is hypovitaminosis D one of the environmental risk factors for multiple sclerosis? Brain 133: 1869–1888.
    • (2010) Brain , vol.133 , pp. 1869-1888
    • Pierrot-Deseilligny, C.1    Souberbielle, J.C.2
  • 41
    • 79958827927 scopus 로고    scopus 로고
    • Widespread vitamin D insufficiency: a new challenge for primary prevention with particular reference to multiple sclerosis
    • Pierrot-Deseilligny C. Souberbielle J.C. (2011) Widespread vitamin D insufficiency: a new challenge for primary prevention with particular reference to multiple sclerosis. Presse Médicale 40: 349–356.
    • (2011) Presse Médicale , vol.40 , pp. 349-356
    • Pierrot-Deseilligny, C.1    Souberbielle, J.C.2
  • 43
    • 28544436950 scopus 로고    scopus 로고
    • Diagnostic criteria for multiple sclerosis: 2005 revisions to the ‘McDonald Criteria’
    • Polman C.H. Reingold S.C. Edan G. Philippi M. Hartung H.P. Kappos L. et al. (2005) Diagnostic criteria for multiple sclerosis: 2005 revisions to the ‘McDonald Criteria’. Ann Neurol 58: 840–846.
    • (2005) Ann Neurol , vol.58 , pp. 840-846
    • Polman, C.H.1    Reingold, S.C.2    Edan, G.3    Philippi, M.4    Hartung, H.P.5    Kappos, L.6
  • 44
  • 45
    • 78650886291 scopus 로고    scopus 로고
    • The 2011 report on dietary reference intakes for calcium and vitamin D from the Institute of Medicine: what clinicians need to know
    • Ross A.C. Manson E.J. Abrams S.A. Aloia J.F. Brannon P.M. Steven K. et al. (2011) The 2011 report on dietary reference intakes for calcium and vitamin D from the Institute of Medicine: what clinicians need to know. J Clin Endocrinol Metab 96: 53–58.
    • (2011) J Clin Endocrinol Metab , vol.96 , pp. 53-58
    • Ross, A.C.1    Manson, E.J.2    Abrams, S.A.3    Aloia, J.F.4    Brannon, P.M.5    Steven, K.6
  • 46
    • 68049101203 scopus 로고    scopus 로고
    • Peripheral blood regulatory T cell measurements correlate with serum vitamin D levels in patients with multiple sclerosis
    • Royal W. III Mia Y. Li H. Nauton K. (2009) Peripheral blood regulatory T cell measurements correlate with serum vitamin D levels in patients with multiple sclerosis. J Neuroimmunol 213: 135–141.
    • (2009) J Neuroimmunol , vol.213 , pp. 135-141
    • Royal, W.1    Mia, Y.2    Li, H.3    Nauton, K.4
  • 47
    • 77953808199 scopus 로고    scopus 로고
    • Addressing vitamin D deficiency in Canada: a public health innovation whose time has come
    • Schwalfenberg G.K. Genuis S.J. Hiltz M.N. (2010) Addressing vitamin D deficiency in Canada: a public health innovation whose time has come. Public Health 124: 350–359.
    • (2010) Public Health , vol.124 , pp. 350-359
    • Schwalfenberg, G.K.1    Genuis, S.J.2    Hiltz, M.N.3
  • 49
    • 39849095055 scopus 로고    scopus 로고
    • Vitamin D as an immune modulator in multiple sclerosis, a review
    • Smolders J. Damoiseaux J. Menheree P. Hupperts R. (2008 a) Vitamin D as an immune modulator in multiple sclerosis, a review. J Neuroimmunol 194: 7–17.
    • (2008) J Neuroimmunol , vol.194 , pp. 7-17
    • Smolders, J.1    Damoiseaux, J.2    Menheree, P.3    Hupperts, R.4
  • 50
    • 81255152070 scopus 로고    scopus 로고
    • Efficacy of vitamin D. (3) as add-on therapy in patients with relapsing-remitting multiple sclerosis receiving subcutaneous interferon beta 1-a: a phase II, multicenter, double-blind, randomized, placebo-controlled trial
    • Smolders J. Hupperts R. Barkhof R. Grimaldi L.M. Holmoy T. Killestein J. et al. (2011 a) Efficacy of vitamin D (3) as add-on therapy in patients with relapsing-remitting multiple sclerosis receiving subcutaneous interferon beta 1-a: a phase II, multicenter, double-blind, randomized, placebo-controlled trial. J Neurol Sci 311: 44–49.
    • (2011) J Neurol Sci , vol.311 , pp. 44-49
    • Smolders, J.1    Hupperts, R.2    Barkhof, R.3    Grimaldi, L.M.4    Holmoy, T.5    Killestein, J.6
  • 51
    • 84863583814 scopus 로고    scopus 로고
    • Association of vitamin D metabolite levels with relapse rate and disability in multiple sclerosis
    • Smolders J. Menheere P. Kessels A. Damoiseaux J. Hupperts R. (2008 b) Association of vitamin D metabolite levels with relapse rate and disability in multiple sclerosis. Mult Scler 14: 1–5.
    • (2008) Mult Scler , vol.14 , pp. 1-5
    • Smolders, J.1    Menheere, P.2    Kessels, A.3    Damoiseaux, J.4    Hupperts, R.5
  • 52
    • 81255135921 scopus 로고    scopus 로고
    • Vitamin D in the healthy and inflamed central nervous system: access and function
    • Smolders J. Moen S.M. Damoiseaux J. Huitinga I. Holmoy T. (2011 b) Vitamin D in the healthy and inflamed central nervous system: access and function. J Neurol Sci 311: 37–43.
    • (2011) J Neurol Sci , vol.311 , pp. 37-43
    • Smolders, J.1    Moen, S.M.2    Damoiseaux, J.3    Huitinga, I.4    Holmoy, T.5
  • 53
    • 78650790685 scopus 로고    scopus 로고
    • Safety and T cell modulating effects of high dose vitamin D 3 supplementation in multiple sclerosis
    • Smolders J. Peelen E. Thewissen M. Cohen Tervaet J.W. Menheere P. et al. (2010) Safety and T cell modulating effects of high dose vitamin D 3 supplementation in multiple sclerosis. PloS ONE 5 (12): e15235.
    • (2010) PloS ONE , vol.5 , Issue.12 , pp. e15235
    • Smolders, J.1    Peelen, E.2    Thewissen, M.3    Cohen Tervaet, J.W.4    Menheere, P.5
  • 54
    • 68949140898 scopus 로고    scopus 로고
    • Vitamin D status is positively correlated with regulatory T cell function in patients with multiple sclerosis
    • Smolders J. Thewissen M. Peelen E. Menheere P. Tervaert J.W. Damoiseaux J. et al. (2009) Vitamin D status is positively correlated with regulatory T cell function in patients with multiple sclerosis. PloS ONE 4: e6635.
    • (2009) PloS ONE , vol.4 , pp. e6635
    • Smolders, J.1    Thewissen, M.2    Peelen, E.3    Menheere, P.4    Tervaert, J.W.5    Damoiseaux, J.6
  • 55
    • 84859612741 scopus 로고    scopus 로고
    • A randomised, double blind, placebo controlled trial with vitamin D 3 as an add-on treatment to interferon β-1b in patients with multiple sclerosis
    • Soilu-Hänninen M. Aivo J. Lindström B.M. Elovaara I. Sumelhati M.L. Färkkilä M. et al. (2012) A randomised, double blind, placebo controlled trial with vitamin D 3 as an add-on treatment to interferon β-1b in patients with multiple sclerosis. J Neurol Neurosurg Psychiatry 83: 565–571.
    • (2012) J Neurol Neurosurg Psychiatry , vol.83 , pp. 565-571
    • Soilu-Hänninen, M.1    Aivo, J.2    Lindström, B.M.3    Elovaara, I.4    Sumelhati, M.L.5    Färkkilä, M.6
  • 56
    • 77956182419 scopus 로고    scopus 로고
    • Vitamin D and musculoskeletal health, cardiovascular disease, autoimmunity and cancer: recommendations for clinical practice
    • Souberbielle J.C. Body J.J. Lappe J.M. Plebani M. Shoenfeld Y. Wang T.J. et al. (2010) Vitamin D and musculoskeletal health, cardiovascular disease, autoimmunity and cancer: recommendations for clinical practice. Autoimmun Rev 9: 709–715.
    • (2010) Autoimmun Rev , vol.9 , pp. 709-715
    • Souberbielle, J.C.1    Body, J.J.2    Lappe, J.M.3    Plebani, M.4    Shoenfeld, Y.5    Wang, T.J.6
  • 57
    • 34249079725 scopus 로고    scopus 로고
    • Vitamin D levels in people with multiple sclerosis and community controls in Tasmania, Australia
    • van der Mei I.A. Ponsonby A.L. Dwyer T. Blizzard L. Taylor B.V. Kilpatrick T. et al. (2007) Vitamin D levels in people with multiple sclerosis and community controls in Tasmania, Australia. J Neurol 254: 581–590.
    • (2007) J Neurol , vol.254 , pp. 581-590
    • van der Mei, I.A.1    Ponsonby, A.L.2    Dwyer, T.3    Blizzard, L.4    Taylor, B.V.5    Kilpatrick, T.6
  • 59
    • 33744933930 scopus 로고    scopus 로고
    • What is the optimal vitamin D status for health?
    • Vieth R. (2006) What is the optimal vitamin D status for health? Prog Biophys Mol Biol 92: 26–32.
    • (2006) Prog Biophys Mol Biol , vol.92 , pp. 26-32
    • Vieth, R.1
  • 61
    • 77955052903 scopus 로고    scopus 로고
    • Common genetic determinants of vitamin D insufficiency: a genome-wide association study
    • Wang T.J. Zhang F. Richards B. Kestenbaum B. van Meurs J.B. Berry D. et al. (2010) Common genetic determinants of vitamin D insufficiency: a genome-wide association study. Lancet 376: 180–188.
    • (2010) Lancet , vol.376 , pp. 180-188
    • Wang, T.J.1    Zhang, F.2    Richards, B.3    Kestenbaum, B.4    van Meurs, J.B.5    Berry, D.6
  • 62
    • 23944470825 scopus 로고    scopus 로고
    • A pilot study of oral calcitriol (1,25-dihydroxyvitamin D3) for relapsing-remitting multiple sclerosis
    • Wingerchuck D.M. Lesaux J. Rice J.P. Kremenchtzky M. Ebers G.C. (2005) A pilot study of oral calcitriol (1,25-dihydroxyvitamin D3) for relapsing-remitting multiple sclerosis. J Neurol Neurosurg Psychiatry 76: 1294–1296.
    • (2005) J Neurol Neurosurg Psychiatry , vol.76 , pp. 1294-1296
    • Wingerchuck, D.M.1    Lesaux, J.2    Rice, J.P.3    Kremenchtzky, M.4    Ebers, G.C.5
  • 63
    • 42249085423 scopus 로고    scopus 로고
    • Blood biomarkers on vitamin D status
    • Zerwekh J.E. (2008) Blood biomarkers on vitamin D status. Am J Clin Nutr 87: 1087S–1091S.
    • (2008) Am J Clin Nutr , vol.87 , pp. 1087S-1091S
    • Zerwekh, J.E.1


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.